Contraception News and Research

Latest Contraception News and Research

Abbvie’s HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval

AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis.

23 Dec 2014

Research outlines new model for measuring acceptability of contraceptive vaginal ring

The Population Council published new research in the November issue of the journal Contraception demonstrating that an investigational one-year contraceptive vaginal ring containing Nestorone and ethinyl estradiol was found to be highly acceptable among women enrolled in a Phase 3 clinical trial.

18 Dec 2014

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its third U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab).

16 Dec 2014

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Amgen today announced that the U.S. Food and Drug Administration has approved a new indication for XGEVA (denosumab) for the treatment of hypercalcemia of malignancy (HCM) refractory to bisphosphonate therapy.

8 Dec 2014

New NIH funding to help researchers develop drug delivery system to prevent HIV infection in women

The University of Texas Medical Branch is part of a collaboration led by the Oak Crest Institute of Science that received a $20 million grant from the National Institutes of Health to develop a novel intravaginal ring capable of delivering powerful antiretroviral drugs to prevent the spread of sexually transmitted HIV in women. The total award to UTMB is approximately $2.5 million.

26 Nov 2014

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

Mylan announces U.S. launch of generic Loestrin 24 Fe

Mylan Inc. today announced the U.S. launch of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate, which is the generic version of Warner Chilcott's Loestrin 24 Fe.

5 Nov 2014

State exchanges gird for round two

Covered California hopes to enroll more than half a million new residents this year, bringing total participants to about 1.7 million.

17 Oct 2014

Research roundup: Malpractice reforms and doctors' practice; Medicaid expansion's effect

Defensive medicine is considered by many to be a major source of wasteful medical spending in the United States.

17 Oct 2014

New book offers advice on how to meet contraceptive needs of women with chronic medical problems

Women with chronic medical conditions can be at higher risk for complications during pregnancy and therefore require specialized preconception and contraceptive care and counseling. However, many medical providers are hesitant to prescribe contraception to these women due to concerns about the safety of various contraceptives with co-existing medical disorders.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Hubris is the greatest danger in wealthy countries -; a sort of smug assumption that advanced technologies and emergency-preparedness plans guarantee that Ebola and other germs will not spread. It was hubris that left Toronto's top hospitals battling SARS in 2003, long after the virus was conquered in poorer Vietnam. It was hubris that led the World Health Assembly in 2013 to cut the WHO's outbreak-response budget in favor of more programs to treat cancer and heart disease.

14 Oct 2014

Coverage gaps still persist among some populations

The Star Tribune reports on how some American Indians -- even now that the health law is in place -- continue to struggle with costs and other challenges related to securing health insurance. Meanwhile, the St. Louis Post-Dispatch examines how state decisions to expand Medicaid impact residents' options.

10 Oct 2014

Democrats spotlight women's health issues

The issue is figuring prominently in races in Colorado and New Hampshire, where Democratic incumbents are highlighting their differences with Republican challengers.

6 Oct 2014

Obama, health law star in campaign ads

The Center for Public Integrity says there have been more than 300,000 Obama-related ads this election cycle. Elsewhere, abortion figures prominently in Senate races such as Colorado's where Democrats look to push their differences with the GOP.

5 Oct 2014

Health exchange's one-year mark: Looking forward, looking back

As of Oct. 1, the health law's online marketplaces have been up and running for a year. News outlets offer status reports on what appears to have gone well, what problems remain as the second open enrollment period approaches and how these factors are playing politically.

3 Oct 2014

Access to long-term contraception lowers teen pregnancy rates, study says

The study counseled young women on the benefits of using long-lasting contraceptives like intrauterine devices and hormonal implants.

3 Oct 2014

State highlights: Calif. health insurers and contraception coverage; Alaska sues Xerox over Medicaid payment systems

Health insurance policies in California will have to cover all federally approved contraceptives for women by 2016 without charging co-payments under legislation signed this week by Gov. Jerry Brown, countering trends in other states and the U.S. Supreme Court. The bill, SB1053 by Sen. Holly Mitchell, D-Los Angeles, expands state laws that required coverage for most birth-control drugs and devices approved by the U.S. Food and Drug Administration. The new law mandates coverage for all FDA-approved contraception, prohibits co-payments and includes managed-care Medi-Cal plans, which are not expressly covered by current laws (Egelko, 9/27).

30 Sep 2014

Viewpoints: Hospitals helped by Medicaid expansion; why GOP candidates back OTC contraceptives

Now the Department of Health and Human Services has issued a report showing that ... thanks to the Affordable Care Act, hospitals across the country will save $5.7 billion in uncompensated care costs in 2014.

29 Sep 2014

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown.

29 Sep 2014

Contraception News and Research

Latest Contraception News and Research

Abbvie’s HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval

Research outlines new model for measuring acceptability of contraceptive vaginal ring

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

New NIH funding to help researchers develop drug delivery system to prevent HIV infection in women

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Mylan announces U.S. launch of generic Loestrin 24 Fe

State exchanges gird for round two

Research roundup: Malpractice reforms and doctors' practice; Medicaid expansion's effect

New book offers advice on how to meet contraceptive needs of women with chronic medical problems

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Coverage gaps still persist among some populations

Democrats spotlight women's health issues

Obama, health law star in campaign ads

Health exchange's one-year mark: Looking forward, looking back

Access to long-term contraception lowers teen pregnancy rates, study says

State highlights: Calif. health insurers and contraception coverage; Alaska sues Xerox over Medicaid payment systems

Viewpoints: Hospitals helped by Medicaid expansion; why GOP candidates back OTC contraceptives

Chemotherapy, radiotherapy have no negative effect on unborn babies

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in